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Abstract  
To investigate the effect of maternal MitoQ treatment on renal disorders caused by maternal cigarette 
smoke exposure (SE). We have demonstrated that maternal SE during pregnancy increases the risk of 
developing chronic kidney disease (CKD) in adult offspring. Mitochondrial oxidative damage 
contributes to the adverse effects of maternal smoking on renal disorders. MitoQ is a mitochondria-
targeted antioxidant that has been shown to protect against oxidative damage-related pathologies in many 
diseases. Female Balb/c mice (8 weeks) were divided into Sham (exposed to air), SE (exposed to cigarette 
smoke) and SEMQ (exposed to cigarette smoke with MitoQ supplemented from mating) groups. Kidneys 
from the mothers were collected when the pups weaned and those from the offspring were collected at 
13 weeks. Maternal MitoQ supplementation during gestation and lactation significantly reversed the 
adverse impact of maternal SE on offspring’s body weight, kidney mass and renal pathology. MitoQ 
administration also significantly reversed the impact of SE on the renal cellular mitochondrial density 
and renal total reactive oxygen species in both the mothers and their offspring in adulthood. Our results 
suggested that MitoQ supplementation can mitigate the adverse impact of maternal SE on offspring’s 
renal pathology, renal oxidative stress and mitochondrial density in mice offspring.  
 
Introduction  
It has been increasingly recognised that maternal programming during fetal development predisposes the 
offspring to future disease. Maternal smoking imposes a significant adverse impact on fetal renal 
development that determines the future risk of chronic kidney disease (CKD) in adulthood 1. Human 
studies have shown that intrauterine exposure to cigarette smoke (SE) is closely linked to impaired fetal 
renal growth 2. Maternal smoking is associated with a 1.24-times increased risk of child proteinuria 
compared with offspring of non-smoking mothers 3. These phenomena have also been confirmed in our 
mouse model of maternal smoking, which demonstrated that maternal SE leads to renal 
underdevelopment in offspring at birth and renal dysfunction in adulthood 4.  
 
Mitochondria are intracellular organelles that generate the energy required for cellular functions through 
oxidative phosphorylation, which involves a series of oxidation-reduction reactions. During this process, 
reactive oxygen species (ROS) are released as a by-product. Thus, mitochondria are the major source of 
ROS during energy synthesis 5, which is subsequently cleared by the endogenous antioxidants, such as 
manganese superoxide dismutase (MnSOD). Mitochondrial abnormalities, such as the accumulation of 
mitochondrial DNA mutations and damaged mitochondria structure due to metabolic stress, can 
overconsume the antioxidant enzymes or impair the production of antioxidants leading to oxidative stress 
which in turn triggers pro-inflammatory response 6,7. Renal tubular cells contain abundant mitochondria, 
therefore mitochondrial density plays a fundamental role in the pathogenesis of kidney diseases. Growing 
evidence suggests that mitochondrial damage is implicated in the pathophysiology of renal diseases 8,9. 
It has been reported that nicotine can accumulate in the kidney 10. Several studies indicated that maternal 
smoking is closely related to increased levels of oxidative stress in the mothers, infants and newborns 
11,12, and reduced levels of the antioxidant enzymes superoxide dismutase (SOD) in the arteries of 
offspring from nicotine treated rats 13. Moreover, we also demonstrated that oxidative stress and 
mitochondrial dysfunction are closely associated with the adverse effects of maternal smoking on the 
kidney pathology in the male offspring 14,15. 
 
Coenzyme Q10 (CoQ10) is a mitochondrial endogenous antioxidant. It has been shown that CoQ10 
supplementation in mice can lower hepatic oxidative stress and inflammation associated with diet-
induced obesity in mice 16. Amniotic fluid CoQ10 levels are significantly lower among women delivering 
preterm babies, a risk which is increased by maternal smoking 17,18. In addition, plasma CoQ10 levels are 
reduced in smokers 19. However CoQ10 is not a viable treatment option due to  poor bioavailability and 
delayed mitochondrial uptake 20. Mitoquinone mesylate, also known as MitoQ, is a mitochondria-
targeted antioxidant. It consists of a ubiquinone moiety, the same structure to the ubiquinone found in 
CoQ10, which allows its rapid uptake and accumulation in the mitochondria to restore the antioxidant 
efficacy of the mitochondrial respiratory complex 21. As such, it has been reported that MitoQ has a 
protective role against oxidative damage-related pathologies in metabolic 22 and neurodegenerative 
diseases 23. Moreover, our previous study demonstrated that maternal MitoQ supplementation during 
pregnancy and lactation is beneficial in reducing lung inflammatory and oxidative stress responses 
caused by maternal SE in the adult offspring  24. Therefore, this study aimed to investigate whether 
maternal MitoQ supplementation can also mitigate the adverse impact on renal disorders caused by SE 
and whether the benefits of MitoQ administered to the SE mother are transmitted to the fetus and result 
in reduced future risk of CKD.  
 
MATERIALS AND METHODS 
Animal experiments 
The animal experiments were approved by the Animal Care and Ethics Committee at the University of 
Technology Sydney (ACEC#2014-638 and #2016-419). All protocols were performed according to the 
Australian National Health & Medical Research Council Guide for the Care and Use of Laboratory 
Animals. Female Balb/c mice (8 weeks) were housed at 20 ± 2 °C and maintained on a 12:12 hour 
light/dark cycle with ad libitum access to standard laboratory chow and water. After the acclimatisation 
period, mice were divided into three groups: SHAM (exposed to air), SE (exposed to cigarette smoke 
from 2 cigarettes twice daily, 6 weeks before mating and throughout gestation and lactation, as previously 
described 4), and SEMQ (SE mothers supplied with MitoQ (500µM in drinking water 25-27) during 
gestation and lactation). Male breeders and suckling pups stayed in the home cage when the mothers 
were exposed to normal air or cigarette smoke. Pups were weaned at postnatal day 20 and maintained 
without additional intervention.  
 
Since we have previously demonstrated that maternal SE have a greater impact on the male offspring 28, 
only male offspring were assessed in this study. One cohort of pups were randomly selected at postnatal 
day 1 from each litter to prevent selection bias29. The rest of the pups were kept to week 13. The 
birthweight of the latter group was not measured to avoid disturbance to the new born litter and mothers 
and problems with attachment which may influence later results30. Briefly, male offspring were 
euthanized (4% isoflurane, 1% O2, Veterinary companies of Australia, Kings Park, NSW) at adulthood 
(13 weeks). A terminal urine collection was undertaken via direct bladder puncture and the blood was 
collected via cardiac puncture after mice were anesthetized. The kidney tissues were collected and stored 
at -80°C for later analysis.  
Albumin and creatinine assays 
The levels of urinary albumin and creatinine were measured using Murine Microalbuminuria ELISA kit 
(Albuwell M) and Creatinine Companion kit, respectively (Exocell Inc, PA, USA) following the 
manufacturer's instructions. 
 
Kidney histology 
Kidney structure was examined in the male offspring at 13 weeks as previously described. Briefly, fixed 
kidney samples were embedded in paraffin and sectioned. Kidney sections were stained with 
hematoxylin and eosin (H&E) and periodic acid-Schiff (PAS). Glomerular number and size were 
assessed as we have previously described 4  and quantitated using Image J software (National Institute of 
Health, Bethesda, Maryland, USA). 
 
Confocal Microscopy Imaging: 
Confocal laser scanning microscopy images of frozen kidney sections were acquired using Leica SP2 
confocal laser scanning microscope (Leica, Wetzlar, Germany). Data was generated from 5-6 animals/ 
group. Four to 6 Images were collected from each kidney and averaged before the analysis. All imaging 
parameters including laser intensities, Photomultiplier tubes voltage and pinholes were kept constant 
during imaging. For total reactive oxygen species (ROS) detection, CellROX Deep Red (Thermo Fisher 
Scientific, Australia) was used at 5 µM final concentration, images were acquired at 633 nm excitation 
wavelength and detected in the 640-680 nm emission range. MitoTracker Green (Thermo Fisher 
Scientific, Australia) was used for staining the mitochondria at 200nM final concentration, Images were 
acquired at 488 nm excitation wavelength and detected in the 510-550nm emission range.  
 
Western blotting 
Kidney tissues were homogenized in lysis buffer with phosphatase inhibitors (Thermo Fisher Scientific, 
CA, USA). Protein concentrations were measured using DC Protein assay (Bio-rad, Hercules, CA, USA). 
Equal amount of proteins (20 µg) were separated on 4–12% Criterion™ XT Bis-Tris Protein Gel (Bio-
rad, Hercules, CA, USA) and transferred to PVDF membranes. The membranes were blocked with TBS-
0.05% Tween 20 (TBS-T) containing 5% BSA or skim milk for 1 h, before incubation with primary 
antibodies against endogenous antioxidant Manganese superoxide dismutase (MnSOD, 1:2000, 
Millipore, Billerica, MA, USA), translocase of the outer membrane-20 (TOM-20, 1:2000, Santa Cruz 
Biotechnology), fibronectin (1:1000, Abcam, Cambridge, UK), phospho-extracellular signal-regulated 
kinase-1/2 (Erk1/2, 1:1000, Cell Signaling Technology Inc), Erk1/2 (1:1000, Cell Signaling Technology 
Inc), phospho-JNK (1:1000, Cell Signaling Technology Inc, MA, USA), c-JUN N-terminal kinase (JNK, 
1:500, Cell Signaling Technology Inc), phospho-p38 Mitogen-activated protein kinase (MAPK, 1:1000, 
Cell Signaling Technology Inc), p38 MAPK (1:1000, Cell Signaling Technology Inc), transcription 
factor nuclear factor-κ -light-chain-enhancer of activated B cells (NFκB, 1:1000, Cell Signaling 
Technology Inc), phospho-NFκB (1:1000, Cell Signaling Technology Inc), F4/80 (1:1000, Sigma 
Aldrich, New South Wales, Australia), Collagen I (1:500, Santa Cruz Biotechnology, Texas, USA), 
Collagen III (1:500, Santa Cruz Biotechnology, Texas, USA) and Collagen IV (1:500, Santa Cruz 
Biotechnology, Texas, USA) overnight at 4°C,  then followed by secondary antibodies (peroxidase-
conjugated goat anti-mouse or anti-rabbit IgG or rabbit anti-goat IgG,1:2000,Santa Cruz Biotechnology 
Inc). The blots were then incubated in Super Signal West Pico Chemiluminescent substrate (Thermo 
Fisher Scientific, CA, USA) and the membranes were then visualized by an Amersham Imager 600 (GE 
Healthcare, NSW, Australia). Protein band density determined using ImageJ software (National Institute 
of Health, Maryland, USA) was used for densitometry, and β-actin (1:5000, Santa Cruz Biotechnology, 
Texas, USA) was used as the control. 
 
Quantitative real-time PCR  
Total mRNA was isolated from kidney tissues using TRIzol Reagent (LifeTechnologies, CA, USA). First 
strand cDNA was generated using M-MLV Reverse Transcriptase, RNase H, Point Mutant Kit (Promega, 
Madison, WI, USA). Genes of interest were measured using pre-optimized SYBR green primers (Sigma-
Aldrich) and RT-PCR master mix (LifeTechnologies, CA, USA). The primers used in real-time RT-PCR 
experiments were as follows: macrophage chemoattractant protein (MCP)-1 forward primer: 5′-
GTTGTTCACAGTTGCTGCCT-3′, and reverse primer: 5′-CTCTGTCATACTGGTCACTTCTAC-3′. 
Interleukin (IL)-1α, IL-6 and cluster of differentiation (CD) 68 mRNA expressions were measured using 
Taqman probe (IL-1α: ACCTGCAACAGGAAGTAAAATTTGA, NCBI gene references: 
NM_010554.4,mCT192405.0, BC003727.1 , ID: Mm00439620_m1; IL-6: 
ATGAGAAAAGAGTTGTGCAATGGCA, NCBI gene references: 
NM_031168.1,X06203.1,X54542.1, ID: Mm00446190_m1; CD68: 
CACTTCGGGCCATGTTTCTCTTGCA, NCBI gene references: NM_001291058.1, ID: 
Mm03047343_m1)  . The average expression of the control group was assigned as the calibrator against 
which all other samples were expressed as fold difference. The 18S rRNA was used as the house-keeping 
gene for all gene of interest.  
 Mitochondrial DNA copy number 
Genomic DNA was extracted from renal tissue using the DNeasy blood and tissue kit (Qiagen). The 
content of mtDNA was calculated using real-time quantitative PCR by measuring the threshold cycle 
ratio (∆Ct) of the mitochondrial-encoded gene cytochrome c oxidase subunit 1 (COX1) (forward primers 
5’-ACTATACTACTACTAA-CAGACCG-3’, reverse primers 5’-GGTTCTTTTTTTCCGGAGTA-3’) 
vs. the nuclear-encoded gene cyclophilin A (forward primers 5’-ACACGCCATAATGGCACTGG-3’, 
reverse primers 5’-CAGTCTTGGCAGTGCAGAT-3’ as we have previously shown 15.  
 
ATP assay 
ATP determination kit (Thermo Fisher Scientific, CA, USA) was used to extract ATP according to 
manufacturer instructions. In brief, kidney tissues (15-20mg) were homogenized in 0.5ml ice-cold 
Phenol-TE (Sigma-Aldrich, New South Wales, Australia). Chloroform (200µl) and de-ionised water 
(200µl) were added and followed by twenty seconds shaking. Aqueous phase was extracted and ATP 
was determined with luciferin-luciferase assay.  
 
Statistical analysis 
Results are presented as the mean ± S.E.M. The differences between the groups were analysed by one-
way ANOVA followed by post hoc Bonferroni test (Prism 7, Graphpad CA, USA). The differences were 
considered statistically significant at P< 0.05. 
 
RESULTS 
Effects of cigarette smoke exposure on the mothers  
Results in table 1 show that body weight was not different between the SE mothers and control mothers. 
Kidney mass was marginally reduced without statistical significance in the SE mothers. Mitochondrial 
density, total ROS levels, and mitochondrial copy number were significantly increased in the kidney’s 
from the SE mothers (P< 0.01 vs SHAM, Fig. 1).  
 
MitoQ supplementation during gestation and lactation significantly reversed the impact of SE on 
mitochondrial density (P< 0.01 vs SE, Fig. 1a). In addition, renal DNA copy number in the SEMQ 
mothers was similar as the SHAM mothers (Fig.1b). Maternal MitoQ administration also significantly 
ameliorated ROS level in the kidneys (P< 0.01 SEMQ vs SE, Fig.1c).  
 
Effect of maternal cigarette smoke exposure on the growth of the male offspring  
At postnatal day 1, body weight and kidney mass were significantly reduced in the male offspring from 
the SE mothers (P< 0.01 and P< 0.05 vs SHAM, respectively; Table 1). A lower body weight was 
maintained until 13 weeks of age (P< 0.01, Table 1) but kidney mass was only marginally reduced 
without statistical significance in offspring of SE mothers. This is consistent with our previous study 
using the same model 4.  
 
Maternal MitoQ supplementation significantly enhanced body weight at P1 and normalised the body 
weight at week13 of the SEMQ offspring (P< 0.01, Table 1). Moreover, kidney mass was significantly 
normalised in the SEMQ offspring at P1 (P< 0.05 vs SE, Table 1). Interestingly, there were fewer male 
offspring in the SEMQ group in comparison to both SE and control groups.  
 
Effect of maternal cigarette smoke exposure on kidney development  
At 13 weeks, the average number of glomeruli was significantly decreased in the SE offspring compared 
to the SHAM offspring (P< 0.01, Figure 2a). The mature glomerular size in the SE offspring was also 
significantly larger than those of the offspring from the SHAM mothers (P< 0.05, Figure 2b). Maternal 
MitoQ supplementation normalised glomerular number (P<0.01 vs SE) and size in the SEMQ offspring 
(Figure 2a, b). 
 
Effect on renal inflammatory and fibrotic markers and kidney function  
Renal mRNA expression of the pro-inflammatory markers MCP-1 and CD68, in addition to the protein 
levels of F4/80, mice macrophage marker were significantly increased in the offspring kidneys due to 
maternal SE (P< 0.05 vs SHAM offspring, Fig.3a, d, e). The levels of the pro-fibrotic marker fibronectin 
and collagen IV protein were also significantly increased in the offspring kidneys due to maternal SE 
(P< 0.05 vs SHAM offspring, Fig. 4a, d). IL-1α and IL-6 expression, as well as Collagen I,III protein 
levels were not changed by maternal SE (Fig 3b,c, 4b,c). Maternal MitoQ administration ameliorated 
MCP-1 expression although this did not reach statistical significance (Fig. 3a); whereas CD68 expression 
and F4/80 protein level were normalised in the SEMQ offspring (P<0.01 vs SE, Fig.3d; P<0.05 vs SE, 
Fig. 3e).  
 
The urinary albumin-to-creatinine ratio as a marker of renal damage was significantly higher in the SE 
group (P< 0.05, Figure 4e). Maternal MitoQ supplementation showed a trend to normalization of urinary 
albumin-to-creatinine ratio. However, this was not significant (Figure 4e). 
 Effect on renal mitochondrial and stress markers in the offspring  
Altered mitochondrial number and DNA content have been proposed as a surrogate of mitochondrial 
function. Here, mitochondrial density and DNA copy number were significantly increased in the 
offspring from the SE mothers (P< 0.01 and P< 0.05 vs SHAM offspring, respectively; Fig.5a, b). As 
such, total ROS level was significantly increased in SE offspring’s kidneys (P< 0.01 vs SE offspring, 
Figure 5c), with reduced endogenous antioxidant MnSOD level (P<0.01 vs SHAM offspring, Fig.5e). 
We also investigated TOM-20, a mitochondrial outer membrane receptor for the translocation of 
cytosolically synthesized mitochondrial pre-proteins. Renal TOM-20 protein level was significantly 
reduced in the SE offspring (P< 0.05 vs SHAM offspring, Figure 5f).  
 
Cellular oxidative stress level was significantly reduced by maternal MitoQ treatment. Maternal MitoQ 
treatment normalised cellular mitochondrial density (P<0.01 vs SE offspring) and total ROS level 
(P<0.05 vs SE offspring, Fig. 5a, c) although no change in copy number was seen. It also marginally 
improved TOM-20 level (Fig. 5f). There was a trend of increased ATP levels in the SE offspring’s 
kidneys (P=0.27 vs SHAM), which was significantly reduced by maternal MitoQ supplementation 
(P<0.05 SEMQ vs SE, Fig. 5g). 
 
Effect on Receptors for Advanced Glycation End-products (RAGE) pathway 
RAGE is a multi-ligand receptor of the immunoglobulin superfamily, which plays a role in cigarette 
smoke-related disease through the AGEs-RAGE axis 31,32. Our data demonstrated that maternal SE  has 
no effect on RAGE, p38 MAPK, ERK1/2, JNK, and NFκB in the offspring’s kidneys at week 13. MitoQ 
administration also has no effect on these markers (supplementary Figure 1).   
 
 
DISCUSSION 
Maternal smoking during pregnancy affects fetal renal development which is linked to an increased risk 
of CKD in the offspring in the adulthood. We have previously demonstrated that maternal SE 
significantly reduced renal development in the male offspring and induced renal pathology in adulthood 
associated with increased oxidative stress and mitochondrial dysregulation 4,14. Such effects were male 
specific 28. However, it is not clear whether this is due to the direct effect of cigarette smoke on maternal 
mitochondrial DNA, which can be transmitted to the offspring.  
 
In this study, we demonstrated that SE increased mitochondrial density and maternal renal DNA copy 
number and as a consequence increased total ROS levels in the mothers’ kidneys. We additionally 
demonstrated that the administration of the mitochondrial-targeted antioxidant MitoQ during gestation 
and lactation can significantly reverse the impact of SE on the abovementioned renal changes. 
Furthermore, we demonstrated that maternal SE induced renal underdevelopment and renal dysfunction 
in the male offspring at adulthood associated with increased renal inflammatory markers, mitochondrial 
alteration and oxidative stress, which were also ameliorated by maternal MitoQ supplementation. 
Interestingly, mitochondrial DNA copy number and density were increased in both SE mothers and their 
offspring suggesting that smoking during pregnancy can alter mitochondrial DNA predisposing the 
offspring to future kidney disease through foetal programing.  
 
Maternal MitoQ administration reversed the effect of maternal SE on the offspring body weight, kidney 
size at birth, renal development, as well as renal function in the adult offspring. Interestingly, although 
maternal MitoQ administration was able to reverse the effect of maternal SE on renal mitochondrial 
density and total ROS levels in the offspring, it had no effect on mitochondrial DNA copy number. This 
finding suggests that the effect of SE on mitochondrial DNA copy number in the mothers may be 
transmitted to the offspring as mitochondrial DNA is inherited from the maternal lineage. Such change 
can’t be reversed by gestational MitoQ supplementation. However, whether such effect occurs prior to 
gestation requires further validation by examining the females before mating, which is beyond the scope 
of this study. It is important to note that there were less male offspring in the SEMQ group in comparison 
to both SE and control groups. The reason for that is to date unclear and is worth further investigation.	
 
Several studies have indicated that maternal cigarette smoking during pregnancy was the most common 
cause of fetal growth restriction and reduced size of the fetal organs 33,34. We have previously shown, 
using the same animal model, that maternal SE is linked to smaller glomerular size and delayed kidney 
development in the male offspring 4,14. In addition, oxidative stress and mitochondrial dysfunction are 
closely associated with the adverse effects of maternal smoking on offspring’s kidney pathology 14,15. 
Such phenotype has also been presented in the SE offspring in this study, reflected by smaller glomerular 
number with adaptive enlargement of glomerular size and impaired renal function. Mitochondrial DNA 
can only be inherited from the mothers, not the fathers 35. Indeed in this study, the changes in renal 
mitochondrial DNA copy number and density in the SE offspring mirrored that in the SE mothers. While 
mitochondrial number and DNA copy number were deregulated by maternal SE, renal total ROS were 
increased in such offspring in line with increased mitochondrial activity of ATP production, suggesting 
oxidative stress, which is consistent with our previous studies 14,15. Correlatively, the level of 
mitochondrial endogenous antioxidant MnSOD was reduced in the offspring’s kidney in response to 
increased oxidative stress, with lower expression of the mitochondrial import receptor subunit (TOM-
20) which may be induced by increased work load for ATP synthesis.  
 
Oxidative stress is often linked to inflammatory responses and fibrotic changes, which were also 
observed in the SE offspring with increased levels of inflammatory (MCP-1, CD68 and F4/80) and 
fibrotic markers (fibronectin and collagen IV). The AGEs-RAGE interaction has also been shown to 
associate with enhanced production of intracellular ROS, which can mediate further inflammatory 
response 36,37. Several studies have suggested that RAGE can also influence the pathogenesis of renal 
disorders 38,39. Our previous study demonstrated that maternal SE can increase RAGE and its signalling 
elements, as well as promoting oxidative stress and inflammatory responses in offspring’s lung 24. 
However in this study, none of the RAGE signaling elements including RAGE, p38 MAPK, ERK1/2, 
JNK, and NFκB, were changed in the SE offspring’s kidney. These findings suggest that the RAGE 
pathway does not seem to be involved in maternal SE induced inflammatory response in the offspring’s 
kidney. There is also evidence suggesting that inflammatory cell infiltration correlates with both the 
extent of renal fibrosis and the severity of renal damage in CKD 40. Irreversible renal fibrosis is a common 
consequence after renal injury and leads to a gradual loss of kidney function, which is a hallmark of 
CKD. In this study, there was a significant increase in fibronectin level in the SE offspring’s kidney. We 
have previously demonstrated that maternal SE induced subtle pathological changes in the offspring’s 
kidneys at 13 weeks. Increased risk of CKD may prevail if the offspring are exposed to additional insult 
after weaning, such as obesity or diabetes. Such hypothesis requires validation in future studies. 
 
Mitochondrial dysfunction occurs in several human disorders, which is considered as the major driver 
for cellular and organ failure. Adverse effects of cigarette smoke have been attributed to increased 
oxidative stress together with mitochondrial dysregulation, which play a key role in the progression of 
renal injury and development of CKD 41-44. Therefore, therapeutic application of mitochondrial-targeted 
therapies may offer potential alternatives for the prevention and treatment of such conditions, instead of 
the generic antioxidants which are normally poorly taken up by the mitochondria. The most widely 
investigated mitochondria-specific antioxidant to date is MitoQ 21,45. The beneficial effects of MitoQ 
have been reported in various disorders, such as metabolic disease 22, neurodegenerative diseases 23, 
kidney damage related to diabetes 46, Parkinson's disease 47, and liver inflammation in hepatitis C virus 
infection 48. Importantly, our previous study using the same cohort of mice demonstrated that maternal 
MitoQ supplementation during pregnancy and lactation is beneficial in reducing lung inflammatory and 
oxidative stress responses in the adult offspring caused by maternal SE 24. As we have demonstrated that 
oxidative stress plays an important role in maternal SE related renal disorders in the male offspring 4,14,15, 
this study extended the investigation of the impact of maternal MitoQ supplementation on renal disorders. 
 
In the current study, our results showed that MitoQ supplementation during pregnancy can significantly 
mitigate small body weight due to in-utero SE. Moreover, we demonstrated that MitoQ treatment can 
restore smaller kidney size and glomerular numbers with nearly normalised renal function in adult 
offspring from the SE mother. These results suggested that MitoQ exert beneficial effects on offspring’s 
health, despite continuing maternal SE during gestation and lactation. Our results are consistent with 
earlier reports that showed that MitoQ treatment prevented renal disorders in a mouse model of type 1 
diabetes 46. Mukhopadhyay and colleagues also found that MitoQ treatment prevented renal dysfunction 
caused by cisplatin nephrotoxicity 49. Such improvement in the offspring is closely related to reduced 
renal ROS level and normalised mitochondrial density in both mothers and offspring. Interestingly, renal 
MnSOD level was not increased in the offspring as a consequence of maternal administration of MitoQ. 
This was different to that observed in the lungs 24, suggesting that ROS was suppressed by other 
antioxidative mechanisms or due to reduced mitochondrial ATP production. The impact of maternal SE 
on TOM-20, the mitochondrial outer membrane receptor for the translocation of cytosolically 
synthesized mitochondrial preproteins, was partially reversed in SE offspring, suggesting some 
improvement in mitochondrial function. However, mitochondrial DNA copy number was not reversed 
in the SEMQ offspring compared with the SEMQ mothers, suggesting oxidative stress may not be the 
only factor to damage mitochondrial DNA in the offspring. Foetal kidneys are likely to be more 
vulnerable to the damage from the chemicals in the cigarette smoke, since nicotine level is 15% higher 
in the foetal blood than the maternal blood 50. This may also affect the fibronectin level in the offspring’s 
kidney 51, which was also unaffected by maternal MitoQ supplementation although the inflammatory 
markers MCP-1, CD68, F4/80 and ROS level were reduced. As the aim of the study was to determine 
whether MitoQ protects the offspring from maternal smoking we did not include a sham group treated 
with MitoQ. Hence we are unable to be definitive about whether MitoQ may cause changes in the 
parameters studied in “normal’ animals. However, Rodriguez-Cuenca et al, have previously examined 
the long-term consequences of MitoQ on wild-type mice in the absence of injury and demonstrated that 
MitoQ has no effect on mitochondrial function, mitochondrial DNA, food consumption or whole body 
metabolism25.  
In summary, our study demonstrates the beneficial effects of maternal MitoQ supplementation during 
gestation and lactation on renal under development and pathology by maternal SE. It also reduced renal 
ROS accumulation and mitochondrial density in both mothers’ and offspring’s kidneys. Although MitoQ 
was unable to reverse the increase in fibrotic markers, it may still protect the offspring against maternal 
SE induced renal pathology and potentially future CKD through reduction of inflammation and oxidative 
stress. This is yet to be confirmed in future human clinical trials.  
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Figure Legends 
Figure 1. Renal mitochondrial density (a), mitochondrial DNA copy number (b) and total ROS level (c) 
in the mothers. Results are expressed as mean ± SE.**P< 0.01 SE vs Sham, ##P< 0.01 SEMQ vs SE. 
SE: cigarette smoke exposure; SEMQ: cigarette smoke exposure with MitoQ supplementation. 
Representative confocal images of (a and c) showing Mitotracker and Cell Rox staining in the SHAM, 
SE and SEMQ groups respectively (d). 
 
Figure 2. Glomerular number and size in the male offspring at 13 weeks. Results are expressed as mean 
± SE. *P< 0.05, **P< 0.01 SE vs Sham, ## P< 0.01 SEMQ vs SE. SE: cigarette smoke exposure; SEMQ: 
cigarette smoke exposure with MitoQ supplementation. 
 
Figure 3. Renal MCP-1 mRNA expression (a), IL-1α mRNA expression (b), IL-6 mRNA expression (c), 
CD68 mRNA expression (d), F4/80 protein levels (e) in the offspring at 13 weeks. Whole gel images (e) 
in Supplementary Fig.3. Results are expressed as mean ± SE. *P< 0.05, SE vs Sham. ## P<0.01; # P< 
0.05, SEMQ vs SE. SE: cigarette smoke exposure; SEMQ: cigarette smoke exposure with MitoQ 
supplementation. 
 
Figure 4. Renal fibronectin protein levels (a), collagen I protein levels (b), collagen III protein levels (c), 
collagen IV protein levels (d), and Urinary Albumin to creatinine ratio (ACR) in the offspring (e) at 13 
weeks. Whole gel images (a-d) in Supplementary Fig.4, (a) and (b). Results are expressed as mean ± SE. 
*P< 0.05, SE vs Sham. SE: cigarette smoke exposure; SEMQ: cigarette smoke exposure with MitoQ 
supplementation. 
 
Figure 5. Renal cellular mitochondrial density (a), mitochondrial DNA copy number (b), total ROS (c), 
Representative confocal images of (a and c) showing Mitotracker and Cell Rox staining in the SHAM, 
SE and SEMQ groups respectively (d), mitochondrial MnSOD (e), and TOM-20 (f), and ATP (g) in the 
male offspring at 13 weeks. Whole gel images of (e-f) in Supplementary Fig. 5. Results are expressed as 
mean ± SE. *P< 0.05, **P< 0.01 SE vs Sham, # P< 0.05, ## P<0.01 SEMQ vs SE.SE: cigarette smoke 
exposure; SEMQ: cigarette smoke exposure with MitoQ supplementation. 
  
Table 1. Body weight and kidney weights of the mothers and offspring at postnatal day 1 and 13 weeks. 
Mother Control 
(n=9) 
SE 
(n=10) 
SEMQ 
(n=9) 
Body weight (g) 21.8 ± 0.7 21.1 ± 0.9 21.2 ± 0.3 
Kidney weight (g) 0.166± 0.006 0.148 ± 0.006 0.157 ± 0.003 
Kidney % body weight 0.77 ± 0.04 0.71 ± 0.03 0.74 ± 0.02 
Offspring P1 (n=14) (n=11) (n=7) 
Body weight (g) 1.51 ± 0.03 1.30 ± 0.06** 1.65 ± 0.05## 
Kidney weight (g) 0.009 ± 0.0005 0.007 ± 0.0004* 0.009 ± 0.0006# 
Kidney % body weight 0.57 ± 0.03 0.55 ± 0.04 0.55 ± 0.03 
Offspring 13 weeks (n=19) (n=20) (n=14) 
Body weight (g) 25.2 ± 0.2 24.2 ± 0.2 ** 25.1 ± 0.2## 
Kidney weight (g) 0.195 ± 0.004 0.186± 0.003 0.198 ± 0.004 
Kidney % body weight 0.77 ± 0.02 0.77± 0.02 0.79 ± 0.02 
Results are expressed as mean ± SE. **P< 0.01 SE vs Sham, ##P< 0.01 SEMQ vs SE 
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 Supplementary figure 1. Renal protein level of markers on the RAGE pathway. Results are expressed as mean ± 
SE. Erk: extracellular signal-regulated kinase; JNK: c-JUN N-terminal kinase; p38MAPK: p38 Mitogen-activated 
protein kinase; NFκB: nuclear factor-κB; SE: cigarette smoke exposure; SEMQ: cigarette smoke exposure with 
MitoQ supplementation. Original gel images shown in supplementary figure 2(a-c). 
 Supplementary figure 2a. Original blots for β actin, p38 and phospho-p38 in supplementary figure 1. 
 Supplementary figure 2b. Original blots for Erk1/2 and phospho-Erk1/2 in supplementary figure 1. 
 Supplementary figure 2c. Original blots for NFκB, phospho- NFκB  and RAGE in supplementary figure 1. 
 Supplementary figure 3. Original blots for F4/80 in figure 3. 
 
 
 Supplementary figure 4a. Original blots for Figure 4a.  
Supplementary figure 4b. Original blot for Figure 3b-d 
  
  
 
Supplementary figure 5. Original blots for Figure 5e and f. 
 
 
